Progress on the Anti-inflammatory, Anti-cancer Activities and Mechanism of Action of Fucoxanthin

被引:0
|
作者
Zhu Y. [1 ,2 ,3 ]
Luan Q. [1 ]
Zeng F. [4 ]
Wang X. [5 ]
Yuan Y. [3 ]
Cai L. [1 ,2 ,3 ]
机构
[1] Ningbo Innovation Center, College of Biosystems Engineering and Food Science, Zhejiang University, Ningbo
[2] College of Biological and Chemical Engineering, Zhejiang Engineering Research Center for Intelligent Marine Ranch Equipment, NingboTech University, Ningbo
[3] College of Biological and Environmental Sciences, Zhejiang Wanli University, Ningbo
[4] Center for Food Evaluation, State Administration for Market Regulation, Beijing
[5] Ningbo Hongwei Food Co., Ltd., Ningbo
关键词
action mechanism; anti-cancer; anti-inflammatory; fucoxanthin;
D O I
10.13386/j.issn1002-0306.2023040267
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Fucoxanthin is a carotenoid, reddish-brown in color, which is mainly derived from marine organisms such as brown algae and diatoms, and has aroused extensive scientific interest due to its unique chemical structure and abundant biological activities. Studies have shown that fucoxanthin processes significant anti-inflammatory and anti-cancer activities. Its anti-inflammatory mechanisms primarily include inhibiting oxidative stress, regulating inflammatory factors, inducting cell autophagy, and resisting cell apoptosis, etc. The main mechanism of anti-cancer activity includes inducing cell autophagy and apoptosis mechanisms, regulating the cell cycle, inhibiting cell migration, and suppressing cell invasion, among other aspects. In this paper, the research progress of anti-inflammatory and anti-cancer activities and related mechanisms of action of fucoxanthin is briefly summarized, which provides the theoretical basis and reference for further research and development of fucoxanthin. © The Author(s) 2024.
引用
收藏
页码:341 / 350
页数:9
相关论文
共 94 条
  • [1] GOKHAN S H., Inflammation, metaflammation and immunometabolic disorders[J], Nature, 542, 7640, (2017)
  • [2] KORNILUK A, KOPER O, KEMONA H, Et al., From inflammation to cancer[J], Irish Journal of Medical Science, 186, 1, (2017)
  • [3] JAVIER A, SARA G, AZAHARA R, Et al., Anti-inflammatory and anticancer effects of microalgal carotenoids[J], Marine Drugs, 19, 10, (2021)
  • [4] GIUSEPPE R, ESTER C, CLAUDIA P, Et al., Sinonasal side effects of chemotherapy and/or radiation therapy for head and neck cancer:A literature review[J], Cancers, 14, 9, (2022)
  • [5] LIN S L, ZHOU J R., The development of cancer symptom clusters[J], Chinese Journal of Gerontology, 33, 10, (2013)
  • [6] PENG Q Y, ZHANG Y Q., Research progress of myelosuppression related to chemotherapy for breast cancer[J], Clinical Research and Practice, 8, 7, (2023)
  • [7] LIU Y X, LIU J L, GUO K, Et al., Fucoxanthin inhibits LPS-induced cellular inflammatory response through NF-κB signaling pathway[J], Journal of Fujian Normal University(Natural Science Edition), 35, 2, (2019)
  • [8] FANG X H, LI X D, JIANG D S, Et al., Flavoprotein and its activity[J], Journal of Clinical and Pathological Sciences, 42, 5, (2022)
  • [9] ZHANG G L, ZHANG Y T, JIANG H, Et al., Metabolic engineering synthesis of neoxanthin, a key precursor of fucoxanthin[J], South China Fisheries Science, 18, 2, (2022)
  • [10] AHMED S A, MENDONCA P, ELHAG R, Et al., Anticancer effects of fucoxanthin through cell cycle arrest, apoptosis induction, angiogenesis inhibition, and autophagy modulation[J], International Journal of Molecular Sciences, 23, 24, (2022)